Global Orally Disintegrating Tablet Market Report By Drug Class (Anti-Psychotics, Anti-Epileptics, CNS Stimulants, Anxiolytics, Anti-Parkinsonian Drugs, Anti-Hypertensives, NSAIDS, Anti-Allergy Drugs, Proton Pump Inhibitors, Others), By Disease Indication(CNS Diseases, GI Diseases, CVS Disorders, Allergy, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2023-2032
The global demand for Orally Disintegrating Tablet Market is presumed to reach the valuation of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% during the period of 2022-2028.
Orally Disintegrating Tablet is a solid drug dosage that can dissolve or disintegrate in the patient's mouth within 60 seconds without water. It is a preferred alternative to conventional tablets and capsules. They are a good alternative for patients with difficulty swallowing, who experience nausea and vomiting, patients who suffer from neurological disorders including older adults and kids. These tablets provide accurate dosing, pre gastric absorption of drugs and are quickly absorbed into the blood circulation. They are taste-masked using microparticles to avoid the bitter aftertaste. Orally disintegrating tablets can be considered a patient-centric drug delivery mechanism that are quite robust with multiple drug packaging configurations and high drug loading capability.
The growth of this market is driven by the rise in the adoption of a compliant drug form by the geriatric and paediatric population. There is a rise in diseases associated with the central nervous system which can affect the conventional drug handling capacity of the patients. Hence this segment can lead to a high gain in the market. Increased acceptance of technologically advanced products and a rise in awareness can boost the market. The main challenging factor is the hurdles in the formulation of high doses for orally disintegrating tablets.
The report covers Porter's Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level.
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of orally disintegrating tablet.
The entire orally disintegrating tablet market has been sub-categorized into drug class, disease indication and distribution channel. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
By Drug Class
Proton Pump Inhibitors
By Disease Indication
By Distribution Channel
This section covers regional segmentation which accentuates on current and future demand for orally disintegrating tablet market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
Global Orally Disintegrating Tablet Market Share by Region (Representative Graph)
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the orally disintegrating tablet market include Teva Pharmaceutical Industries Ltd., Novartis AG, AstraZeneca, Mylan N.V., Pfizer Inc., Johnson & Johnson Services, Inc., F. Hoffmann-La Roche Ltd., Merck & Co., Inc., Bausch Health, GlaxoSmithKline plc, Sun Pharmaceutical Industries Ltd., Others. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers& acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.
1 . PREFACE
1.1. Report Description
1.1.2. Target Audience
1.1.3. Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Market Research Process
1.3.2. Market Research Methodology
2 . EXECUTIVE SUMMARY
2.1. Highlights of Orally Disintegrating Tablet Market
2.2. Global Orally Disintegrating Tablet Market Snapshot
3 . ORALLY DISINTEGRATING TABLET – INDUSTRY ANALYSIS
3.2. Market Drivers of Orally Disintegrating Tablet Market
3.3. Market Restraints of Orally Disintegrating Tablet Market
3.4. Opportunities of Orally Disintegrating Tablet Market
3.5. Trends of Orally Disintegrating Tablet Market
3.6. Porter's Five Force Analysis of Orally Disintegrating Tablet Market
3.7. Orally Disintegrating Tablet Market Attractiveness Analysis
3.7.1 Market Attractive Analysis by Drug Class
3.7.2 Market Attractive Analysis by Disease Indication
3.7.3 Market Attractive Analysis by Distribution Channel
3.7.4 Market Attractive Analysis by Region
4 . VALUE CHAIN ANALYSIS
4.1. Orally Disintegrating Tablet Value Chain Analysis
4.2. Orally Disintegrating Tablet Raw Material Analysis
4.2.1. List of Raw Materials
4.2.2. Orally Disintegrating Tablet Raw Material Manufactures List
4.2.3. Price Trend of Orally Disintegrating Tablet Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
4.4.1. Direct Marketing
4.4.2. Indirect Marketing
4.4.3. Marketing Channel Development Trend
5 . GLOBAL ORALLY DISINTEGRATING TABLET MARKET ANALYSIS BY DRUG CLASS
5.1 Overview by Drug ...